4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0002132312-26-000004
Options or other derivatives
- Chief Operating Officer acquired 400,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Aggarwal Ajay · Chief Operating Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-27 | Grant or award : show line 1 in the form Stock Options | +400,000 | 400,000 | D |
Loading xslF345X06/ownership.xml…